In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin

References

• ChabnerBARobertsTGJrTimeline: chemotherapy and the war on cancerNat Rev Cancer200551657215630416
   PubMed Web of Science ®Google Scholar
• WeisseABFrom trench warfare to war on cancer: the development of chemotherapy for malignant diseaseHosp Pract (Off Ed)1992273A141143147148
   Web of Science ®Google Scholar
• DasariSTchounwouPBCisplatin in cancer therapy: molecular mechanisms of actionEur J Pharmacol201474036437825058905
   PubMed Web of Science ®Google Scholar
• JohnstoneTCSuntharalingamKLippardSJThe next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugsChem Rev201611653436348626865551
   PubMed Web of Science ®Google Scholar
• BoseRNBiomolecular targets for platinum antitumor drugsMini Rev Med Chem20022210311112370072
   PubMed Web of Science ®Google Scholar
• CvitkovicECumulative toxicities from cisplatin therapy and current cytoprotective measuresCancer Treat Rev19982442652819805507
   PubMed Web of Science ®Google Scholar
• DharSKolishettiNLippardSJFarokhzadOCTargeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivoProc Natl Acad Sci U S A201110851850185521233423
   PubMed Web of Science ®Google Scholar
• DharSGuFXLangerRFarokhzadOCLippardSJTargeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticlesProc Natl Acad Sci U S A200810545173561736118978032
   PubMed Web of Science ®Google Scholar
• HallMDMellorHRCallaghanRHambleyTWBasis for design and development of platinum(IV) anticancer complexesJ Med Chem200750153403341117602547
   PubMed Web of Science ®Google Scholar
• GiacconeGClinical perspectives on platinum resistanceDrugs200059Suppl 4917 discussion 37–38
   PubMed Web of Science ®Google Scholar
• BrandonRJDabrowiakJCSynthesis, characterization, and properties of a group of platinum (IV) complexesJ Med Chem19842778618656330359
   PubMed Web of Science ®Google Scholar
• ShiYLiuSAKerwoodDJGoodismanJDabrowiakJCPt(IV) complexes as prodrugs for cisplatinJ Inorg Biochem2012107161422169035
   PubMed Web of Science ®Google Scholar
• LiuDHeCWangAZLinWApplication of liposomal technologies for delivery of platinum analogs in oncologyInt J Nanomedicine2012833093319
   Web of Science ®Google Scholar
• HeCLuJLinWHybrid nanoparticles for combination therapy of cancerJ Control Release201521922423626387745
   PubMed Web of Science ®Google Scholar
• HeCLuKLiuDLinWNanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cellsJ Am Chem Soc2014136145181518424669930
   PubMed Web of Science ®Google Scholar
• Della RoccaJLinWNanoscale metal-organic frameworks: magnetic resonance imaging contrast agents and beyondEur J Inorg Chem20102437253734
   Web of Science ®Google Scholar
• Taylor-PashowKMLDella RoccaJXieZTranSLinWPostsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug deliveryJ Am Chem Soc200913140142611426319807179
   PubMed Web of Science ®Google Scholar
• DharSDanielWLGiljohannDAMirkinCALippardSJPolyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheadsJ Am Chem Soc200913141146521465319778015
   PubMed Web of Science ®Google Scholar
• ShiYGoodismanJDabrowiakJCCyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatinInorg Chem201352169418942623889547
   PubMed Web of Science ®Google Scholar
• MaPAXiaoHHLiCXInorganic nanocarriers for platinum drug deliveryMater Today (Kidlington)20151810554564
   Google Scholar
• RoccaJDWernerMEKramerSAPolysilsesquioxane nanoparticles for triggered release of cisplatin and effective cancer chemoradiotherapyNanomedicine20151113138
   PubMed Web of Science ®Google Scholar
• Della RoccaJHuxfordRCComstock-DugganELinWPolysilsesquioxane nanoparticles for targeted platin-based cancer chemotherapy by triggered releaseAngew Chem Int Ed Engl20115044103301033421915976
   PubMed Web of Science ®Google Scholar
• AngelosSJohanssonEStoddartJFZinkJIMesostructured silica supports for functional materials and molecular machinesAdv Funct Mater2007171422612271
   Web of Science ®Google Scholar
• SlowingIIVivero-EscotoJLWuCWLinVSMesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriersAdv Drug Deliv Rev200860111278128818514969
   PubMed Web of Science ®Google Scholar
• Vivero-EscotoJLHuangYTInorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applicationsInt J Mol Sci20111263888392721747714
   PubMed Web of Science ®Google Scholar
• Vivero-EscotoJLSlowingIITrewynBGLinVSMesoporous silica nanoparticles for intracellular controlled drug deliverySmall20106181952196720690133
   PubMed Web of Science ®Google Scholar
• WuKCYamauchiYControlling physical features of mesoporous silica nanoparticles (MSNs) for emerging applicationsJ Mater Chem201222412511256
   Web of Science ®Google Scholar
• GuJSuSLiYHeQZhongJShiJSurface modification-complexation strategy for cisplatin loading in mesoporous nanoparticlesJ Phys Chem Lett201012434463450
   Web of Science ®Google Scholar
• GuJLiuJLiYZhaoWShiJOne-pot synthesis of mesoporous silica nanocarriers with tunable particle sizes and pendent carboxylic groups for cisplatin deliveryLangmuir201329140341023214476
   PubMed Web of Science ®Google Scholar
• ZhuXGuJLiYZhaoWShiJMagnetic core-mesoporous shell nanocarriers with drug anchorages suspended in mesopore interior for cisplatin deliveryMicroporous Mesoporous Mater2014196115121
   Web of Science ®Google Scholar
• AhnBParkJSinghaKParkHKimWJMesoporous silica nanoparticle-based cisplatin prodrug delivery and anticancer effect under reductive cellular environmentJ Mater Chem B Mater Biol Med201312228292836
   PubMed Web of Science ®Google Scholar
• MohapatraSRoutSRNarayanRMaitiTKMultifunctional mesoporous hollow silica nanocapsules for targeted co-delivery of cisplatin-pemetrexed and MR imagingDalton Trans20144342158411585025224136
   PubMed Web of Science ®Google Scholar
• MunaweeraIShiYKoneruBNitric oxide- and cisplatin-releasing silica nanoparticles for use against non-small cell lung cancerJ Inorg Biochem2015153233126402659
   PubMed Web of Science ®Google Scholar
• Vivero-EscotoJLElnagheebMMesoporous silica nanoparticles loaded with cisplatin and phthalocyanine for combination chemotherapy and photodynamic therapy in vitroNanomaterials20155423022316
   Web of Science ®Google Scholar
• ZhangWShenJSuHCo-delivery of cisplatin prodrug and chlorin e6 by mesoporous silica nanoparticles for chemo-photodynamic combination therapy to combat drug resistanceACS Appl Mater Interfaces2016821133321334027164222
   PubMed Web of Science ®Google Scholar
• MasterAMGuptaASEGF receptor-targeted nanocarriers for enhanced cancer treatmentNanomedicine (Lond)20127121895190623249333
   PubMed Web of Science ®Google Scholar
• ShiMLuJShoichetMSOrganic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancerJ Mater Chem2009193154855498
   Web of Science ®Google Scholar
• YuBOTaiHCXueWLeeLJLeeRJReceptor-targeted nanocarriers for therapeutic delivery to cancerMol Membr Biol201027728629821028937
   PubMed Web of Science ®Google Scholar
• WalkerWATarannumMVivero-EscotoJLCellular endocytosis and trafficking of cholera toxin B-modified mesoporous silica nanoparticlesJ Mater Chem B Mater Biol Med2016471254126227134749
   PubMed Web of Science ®Google Scholar
• YangSJLinFHTsaiKCFolic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cellsBioconjug Chem201021467968920222677
   PubMed Web of Science ®Google Scholar
• ZwickeGLMansooriGAJefferyCJUtilizing the folate receptor for active targeting of cancer nanotherapeuticsNano Rev2012318496
   PubMedGoogle Scholar
• FerreiraTHMarinoARoccaAFolate-grafted boron nitride nanotubes: possible exploitation in cancer therapyInt J Pharm20154811–2566325637832
   PubMedGoogle Scholar
• LiuYMiYZhaoJFengSSMultifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agentsInt J Pharm2011421237037822001536
   PubMed Web of Science ®Google Scholar
• MaXZhaoYNgKWZhaoYIntegrated hollow mesoporous silica nanoparticles for target drug/siRNA co-deliveryChemistry20131946155931560324123533
   PubMed Web of Science ®Google Scholar
• WuHLiuGZhangSBiocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligandsJ Mater Chem201121930373045
   Web of Science ®Google Scholar
• XiongLDuXKleitzFQiaoSZCancer-cell-specific nuclear-targeted drug delivery by dual-ligand-modified mesoporous silica nanoparticlesSmall201511445919592626426251
   PubMed Web of Science ®Google Scholar
• SlowingITrewynBGLinVSEffect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cellsJ Am Chem Soc200612846147921479317105274
   PubMed Web of Science ®Google Scholar
• KikkeriRLepeniesBAdibekianALaurinoPSeebergerPHIn vitro imaging and in vivo liver targeting with carbohydrate capped quantum dotsJ Am Chem Soc200913162110211219199612
   PubMed Web of Science ®Google Scholar
• PatilYBTotiUSKhdairAMaLPanyamJSingle-step surface functionalization of polymeric nanoparticles for targeted drug deliveryBiomaterials200930585986619019427
   PubMed Web of Science ®Google Scholar
• ZhengYRSuntharalingamKJohnstoneTCLippardSJEncapsulation of Pt(IV) prodrugs within a Pt(II) cage for drug deliveryChem Sci2015621189119325621144
   PubMed Web of Science ®Google Scholar
• BarrMPGraySGHoffmannACGeneration and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signaturePLoS One201381e5419323349823
   PubMed Web of Science ®Google Scholar
• LiedertBPluimDSchellensJThomaleJAdduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nucleiNucleic Acids Res2006346e4716571898
   PubMed Web of Science ®Google Scholar
• LundholmLHåågPZongDResistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrestCell Death Dis20134e47823370278
   PubMed Web of Science ®Google Scholar
• PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J200216101217122612153989
   PubMed Web of Science ®Google Scholar